DAIC

JUNE 11, 2024

PFA is designed to address AFib, the most common arrhythmia in the US, with a growing patient population. Another Farapulse PFA study looked at the post-ablation atrial arrhythmia (AA) burden associated with PFA and found less AA burden and improved quality of life in the study population.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. Jennifer Currin, Ph.D.,

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Cardiomatics

NOVEMBER 12, 2024

Cardiovascular diseases, including arrhythmias, are a growing health concern in sub-Saharan Africa. The research team, including experts from UCSF, Weill Cornell Medicine, and Cardiomatics, examined arrhythmia prevalence and ways to build research capacity in the region.

Electrophysiology 52

Electrophysiology Research Arrhythmia Cardiovascular Disease 52

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

DECEMBER 22, 2023

David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

Circulation: Arrhythmia and Electrophysiology

APRIL 3, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Physician-mapper interactions were quantified and classified as high- versus low-quality communications (high quality directly impacted navigation, medical decision-making, or patient care). BACKGROUND:The CommandEP system v2 (Sentiar, St.

Electrophysiology 40

Electrophysiology Patient Care Arrhythmia Ablation 40

DAIC

JULY 30, 2024

During the event, to take place at the Signia by Hilton Atlanta, innovators will gather in one room throughout the conference, gaining insights into regulatory approvals, clinical trials, market adoption, and the integration of novel technologies into patient care.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

DAIC

MAY 17, 2024

ET on Friday, May 17 in the HRS Abstract area to learn more about this study and its impact on the future of cardiac care. David Lin, Cardiologist at the University of Pennsylvania Hospital, will present these trial findings in further detail in the HRS Abstract Area between 3:30 and 5:30 p.m.

Heart Rhythm 52

Heart Rhythm Technology Arrhythmia Stroke 52

Vector Remote

APRIL 14, 2023

Remoting Monitoring as the Standard of Care for CIED Patients At the turn of 21st century, the first fully automatic remote monitoring platform for cardiovascular implantable electronic device (CIEDs) was introduced. Let’s discuss how the future of cardiac remote patient monitoring can help improve your clinic.

Pacemaker 52

Pacemaker Technology COVID-19 Blood Pressure 52

Vector Remote

MARCH 9, 2023

In response, an increasing number of clinics have chosen to rely on cardiac remote patient monitoring ( RPM ) software. This software is transforming preventative healthcare, as it optimizes clinic management and improves patient care. What’s Next in Cardiac Remote Patient Monitoring Software ?

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

GEMMS

MAY 22, 2024

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. GEMMSOne seamlessly integrates with different medical devices.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Wellnest

JUNE 19, 2023

By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. The advances lead to better patient care with accurate diagnosis and treatment. Alternatively, it also helps enhance arrhythmia management with coronary artery disease.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

CineECG

MAY 22, 2023

Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. Exiting news regarding the use of CineECG in localizing the origin of atrial ectopic activity. HRS 2023 is a wrap!

Technology 52

Technology Anatomy Atrial Fibrillation Innovation 52

CardiacWire

DECEMBER 3, 2023

Jimenez and Ali co-founded AccurKardia in 2019 with a vision for unlocking the value of the ECG signal, and the company currently markets one of the few FDA-cleared solutions for automated ECG interpretation and arrhythmia detection. Here’s the rest of their story and vision for ECG automation.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52

Dr. Smith's ECG Blog

JANUARY 15, 2023

It would also pick up a small but important percentage of cases in which an important ECG finding potentially having a direct impact on patient care would have been missed had I not been overreading ECGs. The rhythm in ECG #1 is sinus bradycardia and arrhythmia. If not — Do you think this would be helpful?

Chest Pain 52

Chest Pain Blog Bradycardia Stent 52

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

JULY 10, 2024

In one study, AI enabled multi-class arrhythmia detection with accuracies above 99% in controlled test datasets. Practices should evaluate clinical requirements and goals for virtual care delivery and virtual cardiac telemetry, including the most impactful use cases.

Technology 106

Technology Best Practices AFIB Patient Care 106

DAIC

JANUARY 24, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

Journal of Cardiovascular Electrophysiology

DECEMBER 2, 2024

To improve arrhythmogenic cardiomyopathy (ACM) patient care four pillars of ACM research are necessary. Third, preclinical gene studies can improve ACM patient care to determine which vector has the optimal effect in which specific gene for gene therapy.

Cardiomyopathy 40

Cardiomyopathy Sudden Cardiac Death Patient Care Risk Factors 40

Cardiometabolic Health Congress

AUGUST 8, 2024

One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patient care and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

ADN Center of Excellence

SEPTEMBER 28, 2023

Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Advancements in Cardiology Cardiology is a dynamic field, with ongoing research and technological advancements that continue to transform patient care.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52

EMS 12-Lead

JUNE 1, 2022

The patient advised overall improvement with complete resolution of symptoms. The patient care narrative states no further changes in heart rate with persistent LBBB morphology. Chapter 17: Ventricular Arrhythmias. Hospital transport was unremarkable. He received a permanent pacemaker during the subsequent inpatient stay.

Heart Failure 52

Heart Failure Myocardial Infarction Bradycardia Chest Pain 52

DAIC

APRIL 22, 2025

This can transform clinical practice because the approach provides meaningful information in a clinically pragmatic fashion to facilitate patient care. However, many patients dont know they have the condition until they have symptoms and the disease may already be advanced. and Harry B.

Sudden Cardiac Death 59

Sudden Cardiac Death Electrocardiogram Hospital Research 59

DAIC

APRIL 22, 2025

This can transform clinical practice because the approach provides meaningful information in a clinically pragmatic fashion to facilitate patient care. However, many patients dont know they have the condition until they have symptoms and the disease may already be advanced. and Harry B.

Sudden Cardiac Death 52

Sudden Cardiac Death Electrocardiogram Hospital Research 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Finally, much of this correlates well with The new Canadian Syncope Arrhythmia Risk Score , just published in 2016, results of which are given below in the Annotated Bibliography. The most recent and probably best study is this: Canadian Syncope Arrhythmia Risk Score. Vasovagal syncope is generally benign. Thiruganasambandamoorthy, V.,

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Cardiometabolic Health Congress

JANUARY 2, 2025

Heart rate decrease criteria: >20% decrease, HR <100 bpm, or arrhythmia cessation. Keep following the Cardiometabolic Health Congress (CMHC) for continuous education and engagement with the latest clinical research to advance clinical practices and patient care. Placebo: 0%-11%. Adverse events : Landiolol: 9.9%.

Coronary Artery Disease 52

Coronary Artery Disease Stent Stents Innovation 52